The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125768181 12576818 1 I 20160711 20160720 20160720 EXP US-FRESENIUS KABI-FK201604547 FRESENIUS KABI FRIEDMAN M,LACOUTURE M,DANG C. DERMATOLOGIC ADVERSE EVENTS ASSOCIATED WITH USE OF ADJUVANT LAPATINIB IN COMBINATION WITH PACLITAXEL AND TRASTUZUMAB FOR HER2-POSITIVE BREAST CANCER: A CASE SERIES ANALYSIS. CLINICAL BREAST CANCER 2016 JUN;16 (3):E 69-E 74. 52.00 YR F Y 0.00000 20160720 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125768181 12576818 1 PS PACLITAXEL (Manufacturer unknown) PACLITAXEL 1 Unknown U 77574 UNKNOWN
125768181 12576818 2 SS LAPATINIB LAPATINIB 1 0
125768181 12576818 3 SS TRASTUZUMAB TRASTUZUMAB 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125768181 12576818 1 Intraductal proliferative breast lesion
125768181 12576818 2 Intraductal proliferative breast lesion
125768181 12576818 3 Intraductal proliferative breast lesion

Outcome of event

Event ID CASEID OUTC COD
125768181 12576818 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125768181 12576818 Dermatitis acneiform
125768181 12576818 Diarrhoea
125768181 12576818 Fatigue
125768181 12576818 Rash maculo-papular

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found